Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (877) Lunesta (eszopiclone), Sepracor,
...Newly Approved Drug Therapies (877) Lunesta (eszopiclone), Sepracor, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Lunesta (eszopiclone) Company: Sepracor Approval Status: Approved December 2004 Treatment Area: Insomnia General Information Lunesta (eszopiclone ...
View Page

2.  CenterWatch: New Medical Therapies in Disease Category (97), Depression (Major/Severe)
...announced positive preliminary results of a phase IIIb/IV trial of their recently approved drug Lunesta (eszopiclone) , for the treatment of insomnia in patients with co-morbid major depression. These data indicated that co-administration of Lunesta and fluoxetine (Prozac) significantly improved primary and secondary symptoms of insomnia vs. fluoxetine plus placebo ...
View Page

3.  CenterWatch: New Medical Therapies in Disease Category (164), Depression
...announced positive preliminary results of a phase IIIb/IV trial of their recently approved drug Lunesta (eszopiclone) , for the treatment of insomnia in patients with co-morbid major depression. These data indicated that co-administration of Lunesta and fluoxetine (Prozac) significantly improved primary and secondary symptoms of insomnia vs. fluoxetine plus placebo ...
View Page

4.  CenterWatch: New Medical Therapies in Disease Category (189), Insomnia
...announced positive preliminary results of a phase IIIb/IV trial of their recently approved drug Lunesta (eszopiclone) , for the treatment of insomnia in patients with co-morbid major depression. These data indicated that co-administration of Lunesta and fluoxetine (Prozac) significantly improved primary and secondary symptoms of insomnia vs. fluoxetine plus placebo ...
View Page

5.  CenterWatch: Neurology Approved Drug Therapies
...treatment of acute, intermittent hypomobility episodes associated with advanced Parkinson’s disease, Approved April, 2004 Lunesta (eszopiclone) ; Sepracor; For the treatment of insomnia and sleep maintenance, Approved December 2004 Lyrica (pregabalin ...
View Page

6.  CenterWatch: List of Newly Approved Drug Thearapies
...treatment of acute, intermittent hypomobility episodes associated with advanced Parkinson’s disease, Approved April, 2004 Lunesta (eszopiclone) ; Sepracor; For the treatment of insomnia and sleep maintenance, Approved December 2004 Lyrica (pregabalin ...
View Page